AzTrials
AzTrials

Emotional DysregulationProject WAVENCT07034027

A Single-Session Intervention Fostering Emotional Nonreactivity

A study testing Project WAVE (Wise Awareness of Visiting Emotions) in people with Emotional Dysregulation, run by Northwestern University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to evaluate the effectiveness of a novel online single-session intervention (SSI) designed to improve emotion regulation abilities in young adults (ages 18-29). Read more about this study

Who is it for?
Ages 18 to 29 years
Conditions the study is for
Emotional Dysregulation
What is being tested?
Project WAVE (Wise Awareness of Visiting Emotions)
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
550 participants
Where
1 siteUnited States
Study dates
16 Jul 2025to 5 Aug 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 29 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

None listed.

Who cannot join

  • Fail to meet the above-listed inclusion criteria
  • Exit the study prior to condition randomization
  • Fail to pass data integrity measures

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Northwestern University

    Chicago, Illinois, 60611

Other trials in United States

About this study

Official title: Building Emotion Regulation Skills in Young Adults Using an Online Single-Session Intervention: A Randomized Controlled Trial

The purpose of this study is to evaluate the effectiveness of a novel online single-session intervention (SSI) designed to improve emotion regulation abilities in young adults (ages 18-29). The active intervention condition, titled "Project WAVE," uses mindfulness skills training and an emotion exposure to teach participants how to cope with distressing emotions. Project WAVE will be evaluated in comparison with another online activity that controls for nonspecific aspects of single-session interventions.

Being tested
Project WAVE (Wise Awareness of Visiting Emotions), Emotionally Neutral Writing Control

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Project WAVE (Wise Awareness of Visiting Emotions)Behavioural

    Project WAVE is an online, self-directed single-session intervention designed to foster emotional nonreactivity skills in young adults aged 18-29.

  • Emotionally Neutral Writing ControlBehavioural

    The control condition is an online, self-directed single-session activity that includes an emotionally neutral writing task.

Study groups in NCT07034027
Study groupRoleWhat they receive
Project WAVE (Wise Awareness of Visiting Emotions)ExperimentalThe active condition, "Project WAVE," (Wise Awareness of Visiting Emotions) includes 1) an introduction to the program's rationale; 2) psychoeducation about emotion dysregulation, avoidance, and exposure; 3) testimonials from others who describe their experience facing a difficult emotion; 4) an emotion exposure task along with an audio-guided nonreactivity practice; and 5) the creation of a personalized "action plan" usable for continued practice. Project WAVE is designed to take approximately 15-20 minutes.
Receives: Behavioral: Project WAVE (Wise Awareness of Visiting Emotions)
Emotionally Neutral Writing ConditionPlacebo comparatorThe control condition is self-administered and structurally similar to Project WAVE (e.g., includes peer narratives and contains a similar number of writing activities). It is designed to control for non-specific aspects of supportive online activities. The activity involves an emotionally neutral writing task (journaling about daily life events). This control condition is designed to take approximately 10-15 minutes.
Receives: Behavioral: Emotionally Neutral Writing Control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Emotion Intolerance Beliefs.

    Emotion intolerance beliefs will be measured using the Emotion Avoidance Questionnaire (EAQ) Beliefs subscale, a five-item self-report measure of a participant's beliefs about their inability to tolerate emotions (Taylor et al., 2004). Participants will rate their agreement with each statement reflecting how they feel "right now" on a five-point scale. A higher score indicates greater levels of negative beliefs about their ability to tolerate emotions.

    Measured: Data will be collected in both conditions at all time points (pre-intervention, immediate post-intervention, and two-week follow-up).

Secondary outcomes (1)
  1. Perceived Intervention Utility

    Perception of the intervention's utility in teaching nonreactivity will be assessed with the items: "During this activity, to what extent were you able to observe your emotions without getting caught up in them?"; "How much did this activity help you learn how to be nonreactive to distressing emotions?"; "How much do you think being nonreactive to distressing emotions could help you in the future?" (each on a five-point Likert scale ranging from "not at all" to "very much"); and "How likely are you to try being nonreactive to distressing emotions in the future?" (on a five-point Likert scale ranging from "very unlikely" to "very likely"). Participants will also be asked a multi-select question: "Did anything get in the way of being able to complete the nonreactivity practice?" with response options including "It was too hard," "It was confusing," "I didn't find it interesting," "I got distracted," "Something else [write-in]," or "Nothing got in the way."

    Measured: Data will be collected only in Project WAVE and only at immediate post-intervention.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Jun 2025
  2. Study start16 Jul 2025
  3. Primary completion5 Aug 2025
  4. Study completion5 Aug 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
This study uses a two-group between-subjects design.
Masking
Single blind
Who is masked
Participant
Enrolment
550 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07034027
Sponsor's protocol ID
STU00223240
Acronym
Project WAVE
Status last verified
Apr 2026
First submitted
13 Jun 2025
Last updated
29 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Publications

  • Taylor CT, Laposa JM, Alden LE. Is avoidant personality disorder more than just social avoidance? J Pers Disord. 2004 Dec;18(6):571-94. doi: 10.1521/pedi.18.6.571.54792.

    PubMed 15615668
  • Schleider JL, Dobias M, Sung J, Mumper E, Mullarkey MC. Acceptability and Utility of an Open-Access, Online Single-Session Intervention Platform for Adolescent Mental Health. JMIR Ment Health. 2020 Jun 30;7(6):e20513. doi: 10.2196/20513.

    PubMed 32602846
  • Galla BM, Tsukayama E, Park D, Yu A, Duckworth AL. The mindful adolescent: Developmental changes in nonreactivity to inner experiences and its association with emotional well-being. Dev Psychol. 2020 Feb;56(2):350-363. doi: 10.1037/dev0000877.

    PubMed 31961194
  • Baer RA, Smith GT, Lykins E, Button D, Krietemeyer J, Sauer S, Walsh E, Duggan D, Williams JM. Construct validity of the five facet mindfulness questionnaire in meditating and nonmeditating samples. Assessment. 2008 Sep;15(3):329-42. doi: 10.1177/1073191107313003. Epub 2008 Feb 29.

    PubMed 18310597

Questions about this trial

What is this clinical trial studying?

A study testing Project WAVE (Wise Awareness of Visiting Emotions) in people with Emotional Dysregulation, run by Northwestern University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 0 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Emotion Intolerance Beliefs. (time frame: Data will be collected in both conditions at all time points (pre-intervention, immediate post-intervention, and two-week follow-up).). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07034027, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in